2025-26 Clinical Translation CATALYST Funding Opportunity

OICR is currently inviting applications for a new CATALYST funding stream to support research that leverages existing biospecimens and clinical data to validate biomarkers, molecular signatures, immune correlates or other insights that can improve cancer detection, risk stratification or treatment stratification. The vision of the CATALYST funding stream is to honour patient contributions by accelerating discoveries from available clinical samples. No new sample collection is permitted under this funding opportunity.